A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2009
11/11/2009	CN101575363A Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them
11/11/2009	CN101575361A Novel specific polypeptide and application thereof in preparing medicament for diagnosing, preventing and treating severe acute respiratory syndrome caused by coronaviruses
11/11/2009	CN101574520A Methods of administering anti-TNF alpha antibodies
11/11/2009	CN101574515A Application of Lambda interferon in resisting human immunodeficiency virus
11/11/2009	CN101574514A Product for treating myocardial infarction based on chitosan aquagel and growth factor
11/11/2009	CN101574513A Stomachic hericium erinaceum polysaccharide health-care capsule
11/11/2009	CN100558903C Photochemical internalization for delivery of molecules into the cytosol
11/11/2009	CN100558899C Growth hormone fusion protein
11/11/2009	CN100558893C Modulation of eIF4E expression
11/11/2009	CN100558747C Immunogen by using mutant CRM197 of diphtheria toxin as carrier, preparation method, and application
11/11/2009	CN100558745C Specific inhibition of allograft rejection
11/11/2009	CN100558744C Use of a recombinant erythropoietin having high activity and reduced side effects
11/11/2009	CN100558742C Peptide gap junction modulators
11/11/2009	CN100558411C Tenascin-C nucleic acid ligands
11/11/2009	CN100558405C Pharmaceutical compositions comprising cyclosporin
11/11/2009	CN100558398C Modified naturetic compounds, conjugates, and uses thereof
11/11/2009	CN100558397C Methods of treating neurological conditions with hematopoeitic growth factors
11/11/2009	CN100558396C A composition for wound healing and use thereof
11/11/2009	CN100558395C Hybrid peptide modulate immune response
11/11/2009	CN100558360C Amelioration of macular degeneration and other ophthalmic diseases
11/11/2009	CN100558258C Composition and foods for lowering glycemic index
11/11/2009	CN100558243C A process for the extraction, purification and enzymatic modification of soy 7S globulin alpha' subunit for use as hypocholesterolemizing agent
11/10/2009	US7615623 BAG proteins and nucleic acid molecules encoding them
11/10/2009	US7615622 Methods and compositions for reducing heparan sulfate proteoglycan-mediated clearance of factor VIII
11/10/2009	US7615616 Detecting cell wall anchored surface proteins and developing vaccines to diagnose, prevent and treat enterococcus, streptococcus, staphylococcus and bacillus infections
11/10/2009	US7615615 Modified interferon beta with reduced immunogenicity
11/10/2009	US7615611 Human cytokine receptor
11/10/2009	US7615610 Arrestin chimera comprising naturally occurring beta-arrestin-2 and naturally occurring ubiquitin moiety, where arrestin chimera has increased affinity for GPCR, and where increased affinity means that arrestin chimera remains associated with and traffics with GPCR into endosomes
11/10/2009	US7615540 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening
11/10/2009	US7615538 Method for therapy of rheumatoid arthritis
11/10/2009	US7615535 Modulating nitric oxide acitivity with glutathione-dependent formaldehyde dehydrogenase (GS-FDH); for treatment of asthma and impotency, angina, hypertension, and cancer; enzyme inhibitors
11/10/2009	US7615534 Artificially synthesized antimicrobial peptide having antimicrobial property against at least one type of bacteria, where peptide comprises an amino acid sequence composed of at least part of a nuclear diffusion inhibitory signal sequence included in Rev-protein derived from human immunodeficiency virus
11/10/2009	US7615533 Peptide compounds derivatized with a hydrophilic polymer; solubility and circulation half-lives are increased and their immunogenicity is masked
11/10/2009	US7615532 Insulin derivatives
11/10/2009	US7615531 Methods of reducing the likelihood of spontaneous abortion
11/10/2009	US7615530 Multilayer thin film comprising two or more adjacent layers of oppositely charged polyelectrolytes and encapsulated antigenic peptides; vaccine development
11/10/2009	US7615528 Methods for alleviating deleterious effects of 3-deoxyglucosone
11/10/2009	US7615527 Peptides which modulate blood coagulation and methods of use thereof
11/10/2009	US7615379 Exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in cancers; provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer
11/10/2009	US7615360 Use of Saccharomyces cerevisiae erg4 mutants for expressing mammalian glucose transporter
11/10/2009	US7615359 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
11/10/2009	US7615341 Using allelic mutation on human chromosome 8 as diagnostic indicator of degenerative joint disease
11/10/2009	US7615229 useful in inducing a protective immune response against NTHi in an immunized human
11/10/2009	US7615228 Chimeric protein containing specific polypeptide and a conserved fragment of hemagglutin antigen from influenza virus
11/10/2009	US7615225 Methods for treating a subject having cancer by the administration of a conjugate between a variant staphylococcal entertoxin E superantigen and an antibody that binds to the 5T4 antigen
11/10/2009	US7615219 Treatment of decreased blood platelet numbers by neutralizing anti-PACAP antibody or antigen-binding fragment; haemostasis
11/10/2009	US7615217 Modified fusion protein comprising an anti-EGFR immunoglobulin moiety and a cytokine polypeptide moiety linked together
11/10/2009	US7615215 Endothelial growth factor specific immunoglobulin for use in diagnosis, prevention and treatment of vision, inflammatory, diabetic and cell proliferative disorders
11/10/2009	US7615214 For abnormal angiogenesis, such as proliferation or metastasis of solid tumors, arthritis in rheumatoid arthritis, diabetic retinopathy, retinopathy of prematurity, psoriasis
11/10/2009	US7615212 Administering to the joint having systemic onset juvenile idiopathic arthritis an active agent that will reduce the bioavailability of interleukin-1 beta (IL-1 beta) by modifying the transcription, translation or gene expression or by blocking the IL-1 beta recepter;antiinflammatory agent; antipyretics
11/10/2009	US7615210 Treatment of endometriosis
11/10/2009	US7615207 Methods for treating irritable bowel syndrome
11/10/2009	US7614135 Method for making reservoir-based sensor device
11/10/2009	CA2476257C O-alkylated rapamycin derivatives and their use, particularly as immunosuppressants
11/10/2009	CA2411199C Recombinant bacterial phytases and uses thereof
11/10/2009	CA2371213C Inhibitors of carboxypeptidase u
11/10/2009	CA2335903C Novel cyclosporin with improved activity profile
11/10/2009	CA2280612C Amino acid-sugar composition
11/10/2009	CA2251027C Defective viral vaccine particles obtained in vivo or ex vivo
11/10/2009	CA2219963C Interleukin-18-receptor proteins
11/10/2009	CA2197659C Antibacterial composition containing multimeric alpha-lactalbumin
11/09/2009	CA2631071A1 Inhibition of calpain reduces allergic inflammation
11/05/2009	WO2009135190A2 Therapeutic calcium phosphate particles and methods of making and using same
11/05/2009	WO2009135135A2 Fibromodulin formulation for reducing corneal scarring
11/05/2009	WO2009135029A2 Compositions and methods to treat urinary incontinence
11/05/2009	WO2009135019A2 Methods and compositions for prostate cancer immunotherapy
11/05/2009	WO2009134967A2 Use of nucleic acids with reduced pressure therapy
11/05/2009	WO2009134942A1 Assay for pathogenic conformers
11/05/2009	WO2009134917A2 Methods for treating inflammation
11/05/2009	WO2009134883A1 Substances and compositions for enhancing dna repair and methods of use
11/05/2009	WO2009134808A2 Supercharged proteins for cell penetration
11/05/2009	WO2009134420A2 Epigenetic silencing of tumor suppressor genes
11/05/2009	WO2009134396A2 Methods of using corticotropin-releasing factor for the treatment of cancer
11/05/2009	WO2009134380A2 Super fast-acting insulin compositions
11/05/2009	WO2009134281A2 Melanocortin receptor binding mimetibodies, compositions, methods and uses
11/05/2009	WO2009134279A1 Tubulysin d analogues
11/05/2009	WO2009134204A1 RESTORATION OF ESTROGEN RECEPTOR-α ACTIVITY
11/05/2009	WO2009134130A2 Treatment of bleeding with low half-life fibrinogen
11/05/2009	WO2009133940A1 Pharmaceutical agent for promoting the functional regeneration of damaged tissue
11/05/2009	WO2009133939A1 Agent for recruitment of bone-marrow-derived pluripotent stem cell into peripheral circulation
11/05/2009	WO2009133934A1 Agent for controlling labor pain, and agent for preventing or inhibiting premature birth
11/05/2009	WO2009133905A1 Peptide capable of inhibiting activity of human fibroblast growth factor-23 (human fgf-23), and pharmaceutical composition comprising the same
11/05/2009	WO2009133863A1 Immunopotentiating agent comprising ep1 agonist
11/05/2009	WO2009133521A2 Antibodies and vaccines for use in therapeutic and diagnostic methods for alpha-synuclein-related disorders
11/05/2009	WO2009133249A1 Peptide vaccine for influenza virus
11/05/2009	WO2009133247A1 Neurotrophic factor manf and uses thereof
11/05/2009	WO2009133099A2 Insulin precursors for diabetes treatment
11/05/2009	WO2009133071A2 Polyelectrolyte with positive net charge for use as medicament and diagnostic for cancer
11/05/2009	WO2009132575A1 Nattokinase powders with super high activity and producing method thereof
11/05/2009	WO2009132510A1 Lipocalin-2 as a prognostic and diagnostic marker for heart and stroke risks
11/05/2009	WO2009132457A1 Fgf-9 and its use relating to blood vessels
11/05/2009	WO2009132397A1 Methods and agents for modulating the level and/or activity of hif-2 alpha protein
11/05/2009	WO2009109643A3 Use of interleukin-1 conjugates in the treatment of diabetes
11/05/2009	WO2009105780A3 Mntf peptide compositions and methods of use
11/05/2009	WO2009102497A3 Genetic regulation of host defense mechanisms by mucosal exposure to natural interferon alpha species
11/05/2009	WO2009090648A3 Use of antimicrobial polymers for re-sensitization of microorganisms upon emergence of resistance to anti-microbial agents
11/05/2009	WO2009088572A3 Method of treating erythropoietin hyporesponsive anemias
11/05/2009	WO2009062914A3 Blood pressure lowering combination comprising ipp and/or vpp
11/05/2009	WO2009059011A3 Hla-dr binding peptides and their uses
11/05/2009	WO2009046879A3 Use of the combination of npy and nociceptin as a therapeutic agent

1 ... 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 ... 3163